LYPE:XETRA:XETRA-Lyxor MSCI World Health Care TR UCITS ETF - C-EUR EUR (EUR)

ETF | Others |

Last Closing

USD 478.75

Change

-0.35 (-0.07)%

Market Cap

N/A

Volume

480.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-03-27 )

ETFs Containing LYPE:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.30% 64% D 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.30% 65% D 60% D-
Trailing 12 Months  
Capital Gain -1.59% 19% F 25% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -1.59% 21% F 26% F
Trailing 5 Years  
Capital Gain 55.06% 45% F 48% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 55.06% 46% F 46% F
Average Annual (5 Year Horizon)  
Capital Gain 10.98% 66% D+ 66% D+
Dividend Return 10.98% 65% D 64% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 9.25% 65% D 72% C
Risk Adjusted Return 118.75% 96% N/A 96% N/A
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:

There is nothing we particularly dislike